Autoimmune Brain Panel™Published Studies
Intravenous immunoglobulin for the treatment of autoimmune encephalopathy in children with autism
Published: Translational Psychiatry
Study results suggest that the autoimmune targets in the Panel can predict IVIG treatment response in a subset of autism patients.
Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery
PUBLISHED: FRONTIERS IN PSYCHIATRY
A previously asymptomatic, healthy 7-year-old girl experienced an abrupt onset of several physical, neurological, and psychiatric symptoms increasing in intensity over a 3-week period.
Autoantibody biomarkers for basal ganglia encephalitis in Sydenham chorea and pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections
PUBLISHED: FRONTIERS IN PSYCHIATRY
Study reviews the utilization of antineuronal antibodies, measured with the Autoimmune Brain Panel™ (formerly known as the Cunningham Panel™), as biomarkers for infection-triggered autoimmune basal ganglia encephalitis and the significance of the CaMKinase II.
Anti-lysoganglioside and other anti-neuronal autoantibodies in post-treatment Lyme Disease and Erythema Migrans after repeat infection
PUBLISHED: BRAIN, BEHAVIOR & IMMUNITY
The Autoimmune Brain Panel™ test results indicate Lyme disease may trigger an autoimmune dysfunction, as study findings indicate elevated neuronal autoantibodies may be associated with persistent symptoms.
Evaluation of the Panel in PANDAS and PANS: Changes in antineuronal antibody titers parallel changes in patient symptoms
PUBLISHED: JOURNAL OF NEUROIMMUNOLOGY
Study findings support clinical utility of the antineuronal and cell-stimulatory assays comprising the Autoimmune Brain Panel™ as an aid in the diagnosis of an underlying autoimmune etiology in patients with neuropsychiatric symptoms.
An atypical presentation of Pediatric Acute Neuropsychiatric Syndrome responding to plasmapheresis treatment
PUBLISHED: CASE REPORTS IN PSYCHIATRY
Case report: A 15-year-old patient, initially diagnosed with schizophrenia, is tested with the Autoimmune Brain Panel. Results indicate that her symptoms have an autoimmune basis. After receiving proper treatment, she makes a full recovery.